FDA issued a Warning Letter to Sato Pharmaceutical Co., Ltd. on 2/2/2017 as a result of this inspection.
483 Sato Pharmaceutical Feb 2016

483 Sato Pharmaceutical Feb 2016

Samantha Bradley FDA$119.00 - Available Now

FDA investigators audited the Sato Pharmaceutical - Hachioji, Japan facility and issued inspectional observations (via FDA 483) on 12 Feb 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Feb 2016
  • Location: Hachioji, Japan
  • FEI: 3004055563
Add To Cart